Cytori Therapeutics, Inc. (NASDAQ:CYTX) is at least 53.95% than its current record low price of $0.22. There was a 3.37% gain on 4/12/2019 that led the price to move at $0.33. At a recent session, the prices were hovering between $0.32 and $0.3692. This company shares are 6718.18% off its target price of $22.5 and the current market capitalization stands at $4.78M. The recent change has given its price a 22.16% lead over SMA 50 and -89.66% deficit over its 52-week high. The stock witnessed 37.92% gains, 4.68% gains and -10.54% declines for the 1-month, 3-month and 6-month period, respectively. To measure price-variation, we found CYTX’s volatility during a week at 24.68% and during a month it has been found around 13.49%.Cytori Therapeutics, Inc. 13F Filings
At the end of December reporting period, 6 institutional holders increased their position in Cytori Therapeutics, Inc. (NASDAQ:CYTX) by some 196,004 shares, 9 decreased positions by 26,147 and 9 held positions by 286,671. That puts total institutional holdings at 508,822 shares, according to SEC filings. The stock grabbed 1 new institutional investments totaling 8,234 shares while 3 institutional investors sold out their entire positions totaling 2,543 shares.
Multiple company employees have indulged in significant insider trading. Cytori Therapeutics, Inc. disclosed in a document filed with the US Securities and Exchange Commission (SEC) that 10% Owner PostFinance AG has sold 473,831 shares of Cytori Therapeutics, Inc. (CYTX) in the trading session dated Feb. 14, 2018. These shares are worth $161,103 and were traded at $0.34 each. The SEC filing shows that PostFinance AG performed a sale of 286,982 shares. The 10% Owner disposed these shares by way of transaction on Feb. 13, 2018. The company’s shares were given away at $0.31 per share worth to an income of some $88,964 to the account of PostFinance AG.
10% Owner, PostFinance AG, sold 236,155 common shares of Cytori Therapeutics, Inc. (CYTX) in the open market. In a transaction dated Feb. 09, 2018, the shares were put up for sale at an average price of $0.34, raking in a sum of $80,293. After this sale, 5,303,899 common shares of CYTX are directly owned by the insider, with total stake valued at $1,750,287.
In the transaction dated Jan. 11, 2018, a great number of shares sold came courtesy the 10% Owner; Swissquote Bank SA disposed a total of 188,426 shares at an average price of $0.37, amounting to approximately $69,718. The insider now directly owns 5,328,229 shares worth $1,758,316.